Cargando…
Dual-Responsive Core Crosslinking Glycopolymer-Drug Conjugates Nanoparticles for Precise Hepatocarcinoma Therapy
Nanoparticles (NPs) have demonstrated a potential for hepatocarcinoma therapy. However, the effective and safe NP-mediated drug transportation is still challenging due to premature leakage and inaccurate release of the drug. Herein, we designed a series of core cross-linking galactose-based glycopol...
Autores principales: | Wu, Jing, Yuan, Jiayi, Ye, Baotong, Wu, Yaling, Xu, Zheng, Chen, Jinghua, Chen, Jingxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056621/ https://www.ncbi.nlm.nih.gov/pubmed/30065648 http://dx.doi.org/10.3389/fphar.2018.00663 |
Ejemplares similares
-
Preparation of a dual cored hepatoma-specific star glycopolymer nanogel via arm-first ATRP approach
por: Lou, Shaofeng, et al.
Publicado: (2017) -
Synthesis of Glycopolymer Micelles for Antibiotic Delivery
por: Chen, Xuan, et al.
Publicado: (2023) -
YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
por: Guo, Jun, et al.
Publicado: (2021) -
Glycopolymer Code Based on Well-Defined Glycopolymers or Glyconanomaterials and Their Biomolecular Recognition
por: Yilmaz, Gokhan, et al.
Publicado: (2014) -
Glycopolymers for Antibacterial and Antiviral Applications
por: Mei, Ruoyao, et al.
Publicado: (2023)